Welcome to our dedicated page for Avricore Health SEC filings (Ticker: AVCRF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Avricore Health Inc. filings document the company's foreign private issuer reporting and disclosures for the HealthTab pharmacy testing platform. Its Form 6-K reports furnish annual and interim financial statements, management discussion and analysis, officer certifications, and news releases covering HealthTab platform activity.
The filing record also reflects Avricore Health's use of Form 20-F status, Canadian issuer certifications, and material updates related to community pharmacy testing initiatives, including UK expansion materials and health-system pilot disclosures.
Avricore Health Inc. filed a Form 6-K as a foreign private issuer for January 2026. The filing primarily furnishes a news release titled “HealthTab to Expand Across North East London,” indicating the company is highlighting expansion activity related to its HealthTab platform in that region.
Avricore Health Inc. submitted a Form 6-K as a foreign private issuer for November 2025. The filing mainly furnishes a news release titled “HealthTab to Power NHS Pilot”, listed as Exhibit 1 and dated November 27, 2025. The report is signed on behalf of the company by Chief Financial Officer Kiki Smith on December 10, 2025, confirming the news release as official company communication.